Cardiovascular Improvements With MV ASV Therapy in Heart Failure
Status:
Terminated
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to compare the effects of MV targeted ASV in addition to optimized
medical therapy versus optimized medical therapy alone at 6 months in patients with acute
decompensated HF. The study will also assess changes in functional parameters, biomarkers,
quality of life (QOL), and sleep.